Seastar Medical Holding Corporation held its annual meeting of stockholders virtually on July 3, 2025. Stockholders approved the election of Eric Schlorff and Kenneth Van Heel as Class III Directors. An amendment and restatement of the company's 2022 Omnibus Equity Incentive Plan to increase the number of authorized shares of common stock and remove the evergreen provision was approved. The potential future sale and issuance of shares of common stock to Lincoln Park, in accordance with the Lincoln Park Purchase Agreement, was approved. The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, a proposal to adjourn or postpone the meeting if necessary was also approved.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。